Clinical trial
Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass
NCT00587444 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2001
- Completion date
- October 31, 2007
- Enrollment
- 270 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.